BioHarvest Sciences will be webcast live at
The company invites individual and institutional investors, as well as advisors and analysts, to attend real-time interactive presentations at VirtualInvestorConferences.com
VANCOUVER, British Columbia and REHOVOT, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) — BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV), a biotechnology company focused on cell culture without le via its patented CELLicitation platform, today announced that Ilan Sobel, CEO, will present live at VirtualInvestorConferences.com on September 15, 2022.
DATE: September 15, 2022
TIME: 12:30 p.m. ET
Available for 1×1 meetings: September 16, 19, 20
It will be a live, interactive online event where investors are invited to ask questions of the company in real time. If attendees are unable to join the live event on the day of the conference, an archived webcast will also be available after the event.
Investors are recommended to pre-register and run the online system check to expedite participation and receive event updates.
To learn more about the event, visit www.virtualinvestorconferences.com.
Recent Highlights from BioHarvest Sciences
- August 2022 – BioHarvest launched its first major integrated marketing campaign in the United States, including television, promoting VINIA, its unique Piceid Resveratrol supplement derived from red grape cells that supports heart health
- September 2022 – BioHarvest received the Business Intelligence Group’s Sustainability Leadership Award. The award recognizes the sustainability impact of BioHarvest’s Bio Plant CELLicitation technology, which enables the industrial production of plant metabolites without growing the plant itself, using a fraction of the energy, water or land required for traditional or indoor agriculture, without chemicals, solvents or heavy metals.
- May 2022 – BioHarvest announced that it was the first company in the world to grow full-spectrum non-GMO cannabis biomass containing 93% trichomes without growing the plant itself, and is now focusing its efforts on commercializing its consistent, clean and efficient cannabis, produced with the highest ESG credentials and capital efficiency, in North America in the first half of 2023.
- CNVCF (US trading symbol of BioHarvest) started trading on the OTCQB in the summer of 2022
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing biotechnology company listed on the Canadian Stock Exchange. BioHarvest has developed a patented biocellular growth platform technology capable of cultivating the active and beneficial ingredients of fruits and plants, on an industrial scale, without the need to cultivate the plant itself. This technology is economical, provides consistency and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on the nutraceutical and medicinal cannabis markets. Visit: www.bioharvest.com
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading exclusive investor conference series that provides an interactive forum for publicly traded companies to pitch directly to investors.
Providing a real-time investor engagement solution, VIC is uniquely designed to provide companies with more efficient access to investors. Replicating the components of an onsite investor conference, VIC provides companies with enhanced capabilities to connect with investors, schedule targeted one-on-one meetings, and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences deliver top-notch investor communications to a global network of retail and institutional investors.
Organic Harvest Science
Virtual conferences for investors
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group